Product image
InVivoMAb anti-mouse CD8alpha
BE0004-1
ApplicationsFlow Cytometry, ImmunoFluorescence, Western Blot, Other Application
Product group Antibodies
ReactivityMouse
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-mouse CD8alpha
- Delivery Days Customer7
- ApplicationsFlow Cytometry, ImmunoFluorescence, Western Blot, Other Application
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID53-6.7
- Concentration4-11 mg/ml
- HostRat
- IsotypeIgG2a
- ReactivityMouse
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer. Wang W et al., 2018 Nov 12, Cancer CellRead more
- MET is required for the recruitment of anti-tumoural neutrophils. Finisguerra V et al., 2015 Jun 18, NatureRead more
- Suppression of Fcgamma-receptor-mediated antibody effector function during persistent viral infection. Yamada DH et al., 2015 Feb 17, ImmunityRead more
- Depletion of regulatory T cells in a hapten-induced inflammation model results in prolonged and increased inflammation driven by T cells. Christensen AD et al., 2015 Mar, Clin Exp ImmunolRead more
- Animal model of respiratory syncytial virus: CD8+ T cells cause a cytokine storm that is chemically tractable by sphingosine-1-phosphate 1 receptor agonist therapy. Walsh KB et al., 2014 Jun, J VirolRead more
- TNF-alpha-dependent hematopoiesis following Bcl11b deletion in T cells restricts metastatic melanoma. Uddin MN et al., 2014 Feb 15, J ImmunolRead more
- Clonal expansions of CD8+ T cells with IL-10 secreting capacity occur during chronic Mycobacterium tuberculosis infection. Cyktor JC et al., 2013, PLoS OneRead more
- The immunocytokine L19-IL2 eradicates cancer when used in combination with CTLA-4 blockade or with L19-TNF. Schwager K et al., 2013 Mar, J Invest DermatolRead more
- Dacarbazine-mediated upregulation of NKG2D ligands on tumor cells activates NK and CD8 T cells and restrains melanoma growth. Hervieu A et al., 2013 Feb, J Invest DermatolRead more
- The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology. Hafalla JC et al., 2012 Feb, PLoS PathogRead more